2009

Journal Articles (English)

  1. Watanabe K, Matsui M, Matsuzawa J, Tanaka C, Noguchi K, Yoshimura N, Hongo K, Ishiguro M, Wanatabe S, Hirono K, Uese K, Ichida F, Origasa H, Nakazawa J, Oshima Y, Miyawaki T, Yagihara T, Bilker W, Gur RC: Impaired neuroanatomical development in Infants with Congenital Heart Disease. Journal of Thoracic and Cardiovascular Surgery, 137 (1), 146-153, 2009.
  2. Sumiyoshi T, Higuchi Y, Itoh T, Matsui M, Arai H, Suzuki M, Kurachi M, Sumiyoshi C, Kawasaki Y: Effect of perospirone on P300 electrophysiological activity in schizophrenia: A three-dimensional analysis with sLORETA, Psychiatry Research: Neuroimaging, 172 (3), 180-183, 2009.
  3. Matsui M, Arai H, Yonezawa M, Sumiyoshi T, Suzuki M, Kurachi M: The effects of cognitive rehabilitation on social knowledge in patients with schizophrenia. Applied Neuropsychology, 16 (3), 158-164, 2009.
  4. Matsuzaki T, Matsui M, Ichida F, Nakazawa J, Hattori A, Yoshikoshi K, Miyazaki M, Fujii M, Hagino I, Yagihara T: Neurodevelopment in 1-year-old Japanese infants after congenital heart surgery. Pediatrics International, 53(2), in press.

Presentations in International meeting

  1. Matsui M, Suzuki M, Zhou SY, Takahashi T, Kawasaki Y, Yuuki H, Kato K, Kurachi M: Characteristics of memory strategy and prefrontal brain volume and in schizophrenia spectrum disorders. 37th Annual Meeting of International Neuropsychological Society, 2009, 2.11-15, Atlanta.
  2. Sumiyoshi T., Higuchi Y., Itoh T., Matsui M., Arai H., Suzuki M., Sumiyoshi C., Kawasaki Y.: Effect of perospirone on P300 electrophysiological activity and social cognition in schizophrenia: A three-dimensional analysis with sLORETA. 17th European Congress of Psychiatry, 2009, 1.24-28, Lisbon, Portugal.
  3. Watanabe K, Matsui M, Yoshimura N, Hirono K, Ichida F, Ohshima Y, Matsuzaki T, Yagihara T: Impaired neuroanatomic development in infants with congenital heart disease. 5th World Congress of Pediatric Cardiology and Cardiac Surgery. 2009, 6, Cairns, Australia
  4. Matsui M, Arai H, Nakatsubo T, Yonezawa M, Sumiyoshi T, Suzuki M, Kurachi M: The effect of cognitive rehabilitation using car driving simulator in schizophrenia. 2009 Mid-Year Meeting of International Neuropsychological Society, 2009, 7.29-8.1, Helsinki, Finland and Tallinn, Estonia.
  5. Shibata T, Matsui M, Kobayashi S, Chan RC, Shibata T: Study of neurological soft sighs in Japanese patients with schizophrenia. 2009 Mid-Year Meeting of International Neuropsychological Society, 2009, 7.29-8.1, Helsinki, Finland and Tallinn, Estonia.
  6. Sumiyoshi T., Higuchi Y., Matsui M., Itoh H, Itoh T., Arai H, Takamiya C. Uehara T., Suzuki M., Kurachi M.: Membrane fatty acid levels as a predictor of treatment response in schizophrenia. 22nd European Congress of Neuropsychopharmacology, 2009, 6.14, Istanbul, Turkey.
  7. Sumiyoshi T., Higuchi Y., Itoh T., Matsui M., Arai H., Suzuki M., Sumiyoshi C., Kawasaki Y.: Effect of perospirone on P300 electrophysiological activity and social cognition in schizophrenia: A three-dimensional analysis with sLORETA. World Federation of Societies of Biological Psychiatry – The 9th World Congress of Biological Psychiatry, 2009, 7.1, Paris.
  8. Sumiyoshi T., Higuchi Y., Matsui M., Itoh H, Itoh T., Arai H, Takamiya C. Uehara T., Suzuki M., Kurachi M.: Membrane fatty acid levels as a predictor of treatment response in schizophrenia. 1st Asian Congress of Neuropsychopharmacology, 2009, 11.14, Kyoto.